Hosted on MSN23d
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugsEli Lilly Chief Scientific Officer Dan Skovronsky said newer obesity medicines need to deliver more than just weight loss to compete with Zepbound and Wegovy. The development of pills and more ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Indianapolis Star on MSN16d
Eli Lilly will build 4 new manufacturing sites to increase domestic drug productionEli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback